Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomized Cont… (NCT07755540) | Clinical Trial Compass
RecruitingPhase 2
Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomized Controlled Trial
United States130 participantsStarted 2026-03-17
Plain-language summary
This randomized controlled trial will evaluate the effectiveness of an 8-week group music therapy intervention for active duty service members with chronic pain. Participants will be randomized to either a group music therapy intervention plus standard care or standard care alone. Outcomes will be assessed at baseline, post- treatment (8 weeks), and 1-month follow-up. Primary outcomes include pain interference and pain intensity. Secondary outcomes include pain-related self-efficacy, depression, anxiety, positive affect, sleep disturbance, patient perception of change, and pain medication use. Qualitative interviews will be conducted with a subset of participants who receive music therapy to explore subjective experiences and perceived treatment benefits.
Who can participate
Age range
18 Years – 64 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Active duty service member
* Age 18 -64 years of age
* Diagnosis of chronic benign pain for at least 3 months
* Average pain severity greater than 4/10 on the Defense and Veterans Pain Rating Scale
* Able to read and understand English
Exclusion Criteria:
* Pregnancy
* Mental health conditions that would prevent compliance with or productive participation in group sessions
* Cognitive impairment preventing completion of study measures
* Malignant disease
* Progressive neurological disorder
* Moderate to profound hearing impairment not corrected with hearing aids
* Previous participation in music therapy services at JBER
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain Intensity
Timeframe: Baseline, Week 8, and 1-Month Follow-Up as well as pre and post- session
2
Pain Interference
Timeframe: Baseline, Week 8, and 1-Month Follow-Up
Trial details
NCT IDNCT07755540
SponsorHenry M. Jackson Foundation for the Advancement of Military Medicine